Context Therapeutics CNTX Income Statement (2020-2026)

NASDAQ CNTX
$0.52 +0.00 (+0.23%)
As of: Aug 21, 2026 · 12:38 PM EDT
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.35M2.83M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M54.96M75.00M58.42M89.70M89.70M91.88M91.88M91.88M91.88M
Operating items
Research & Development (Quarter)
0.74M1.29M1.35M1.52M2.08M2.14M4.53M3.46M4.49M5.30M1.97M1.38M16.83M2.52M3.46M7.83M8.72M11.84M7.02M12.53M
Selling, General & Administrative (Quarter)
0.83M1.80M2.09M1.99M1.97M1.74M2.13M1.83M1.70M1.63M1.85M1.70M1.88M1.79M2.07M1.93M1.89M1.96M2.33M2.44M
Other Operating Expenses (Quarter)
-3.82M-3.09M-7.68M-10.46M-4.47M-8.27M-9.37M-10.45M-7.44M-7.44M
Operating Expenses (Quarter)
1.57M3.09M3.44M3.51M4.05M3.88M6.67M5.29M6.18M6.93M11.02M-6.15M1.06M1.49M1.24M3.35M1.90M7.53M
Operating Income (Quarter)
-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.82M-3.09M-18.70M-4.31M-5.53M-9.76M-10.61M-13.80M-9.34M-14.97M
EBIT (Quarter)
-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.82M-3.09M-18.70M-4.31M-5.53M-9.76M-10.61M-13.80M-9.34M-14.97M
Non-operating items
Interest & Investment Income (Quarter)
0.15M0.84M1.24M0.96M0.96M0.90M0.83M0.68M0.52M0.42M
Other Non Operating Income (Quarter)
0.00M-0.01M-0.00M0.00M-0.01M0.03M0.08M0.10M0.14M-0.01M
Non Operating Income (Quarter)
0.13M-276.00-0.00M4.000.00M-0.00M0.00M-0.01M0.02M-0.06M0.00M-0.01M-0.00M-0.01M
Net income details
EBT (Quarter)
-1.61M-3.11M-3.44M-4.01M-4.05M-13.07M-6.67M-5.68M-6.79M-23.54M-4.36M-4.06M-19.17M-28.11M-4.57M-8.86M-10.49M-16.06M-18.29M-14.55M
Profit After Tax (Quarter)
-1.44M-3.09M-3.44M-3.99M-3.85M-3.56M-6.31M-5.01M-5.87M-6.77M-3.67M-2.25M-17.46M-3.34M-4.58M-8.83M-9.69M-13.03M-8.68M-14.56M
Income from Continuing Operations (Quarter)
-1.61M-3.11M-3.44M-4.01M-4.05M-13.07M-6.67M-5.68M-6.79M-23.54M-4.36M-4.06M-19.17M-28.11M-4.57M-8.86M-10.49M-16.06M-18.29M-14.55M
Consolidated Net Income (Quarter)
-1.61M-3.11M-3.44M-4.01M-4.05M-13.07M-6.67M-5.68M-6.79M-23.54M-4.36M-4.06M-19.17M-28.11M-4.57M-8.86M-10.49M-16.06M-18.29M-14.55M
Income towards Parent Company (Quarter)
-1.61M-3.11M-3.44M-4.01M-4.05M-13.07M-6.67M-5.68M-6.79M-23.54M-4.36M-4.06M-19.17M-28.11M-4.57M-8.86M-10.49M-16.06M-18.29M-14.55M
Net Income towards Common Stockholders (Quarter)
-1.61M-3.11M-3.44M-4.01M-4.05M-13.07M-6.67M-5.68M-6.79M-23.54M-4.36M-4.06M-19.17M-28.11M-4.57M-8.86M-10.49M-16.06M-18.29M-14.55M
Additional items
EPS (Basic) (Quarter)
-4.47-1.10-0.22-0.25-0.25-0.82-0.42-0.36-0.43-1.47-0.27-0.07-0.24-0.48-0.05-0.09-0.11-0.17-0.19-0.15
EPS (Diluted) (Quarter)
-4.47-1.10-0.22-0.25-0.25-0.82-0.42-0.36-0.43-1.47-0.27-0.07-0.24-0.48-0.05-0.09-0.11-0.17-0.19-0.15
Shares Outstanding (Quarter)
0.36M2.83M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M54.96M80.48M58.42M95.19M95.19M95.19M95.19M95.18M95.18M
Shares Outstanding (Diluted) (Quarter)
0.36M2.83M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M54.96M80.48M58.42M95.19M95.19M95.19M95.19M95.18M95.18M
EBITDA (Quarter)
-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.82M-3.09M-18.70M-4.31M-5.53M-9.76M-10.61M-13.80M-9.34M-14.97M
Interest Expenses (Quarter)
0.05M0.02M9.19M0.39M0.61M16.61M0.69M1.82M1.72M24.76M0.00M0.71M2.94M9.47M